Clinical study with Lyrica (pregabalin) in patients suffering from epilepsy. This drug is
used as adjunctive therapy with one or more antiepileptics. Lyrica has potential to reduce
- Adult patients with partial seizures.
- Contraindications according to Summary of Product Characteristics (SmPC).
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting the study website. Please see the references below: